(Q39519384)

12 September 2017

Longitudinal study of epstein-barr virus antibody titers and excretion in pediatric patients with Hodgkin's disease (English)

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220503

8 November 2022

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A82539

8 November 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220503

8 November 2022

author name string

B. Lange

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A82539

8 November 2022

A. Arbeter

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A82539

8 November 2022

J. Hewetson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A82539

8 November 2022

W. Henle

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A82539

8 November 2022

language of work or name

English

0 references

publication date

1 November 1978

1 reference

12 September 2017

15 November 1978

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=82539

full work available at URL

8 November 2022

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fijc.2910220503

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220503

https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.2910220503

8 November 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220503

International Journal of Cancer

8 November 2022

published in

1 reference

12 September 2017

22

1 reference

12 September 2017

521-527

1 reference

12 September 2017

5

1 reference

Oropharyngeal Excretion of Epstein-Barr Virus by Patients with Lymphoproliferative Disorders and by Recipients of Renal Homografts

12 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FIJC.2910220503

Antibodies to Epstein-Barr virus-associated nuclear antigen in infectious mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FIJC.2910220503

EBV infections in Brazil. I. Occurrence in normal persons, in lymphomas and in leukemias

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220503

Transformation of Human Leucocytes by Throat Washing from Infectious Mononucleosis Patients

8 November 2022

4

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220503

Prevalence of oropharyngeal excreters of leukocyte-transforming agents among a human population

8 November 2022

5

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220503

Cancer incidence following infectious mononucleosis

8 November 2022

7

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220503

8 November 2022

8

34

1172

Connelly

1974

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220503

Oral excretion of Epstein-Barr virus by healthy subjects and patients with infectious mononucleosis

8 November 2022

9

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220503

Incidence of antibody to EB virus, herpes simplex, and cytomegalovirus in Hodgkin's disease

8 November 2022

10

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220503

Antibodies to epstein-barr virus in patients with Hodgkin's disease and leukemia

8 November 2022

11

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220503

Primary Epstein-Barr Virus Infection in a Renal Transplant Recipient

8 November 2022

12

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220503

Epstein-Barr virus specific diagnostic tests in infectious mononucleosis

8 November 2022

15

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220503

Antibody to Epstein-Barr virus and cellular immunity in Hodgkin's disease and chronic lymphatic leukemia

8 November 2022

17

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220503

A case control study on immunity to two epstein-barr virus-associated antigens, and to herpes simplex virus and adenovirus in a population-based group of patients with hodgkin's disease in denmark, 1971–73

8 November 2022

18

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220503

Epstein-Barr virus (EBV)-associated antibody patterns in malignant lymphoma and leukemia. I. Hodgkin's disease

8 November 2022

20

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220503

Antibodies to Epstein-Barr virus, cytomegalovirus, and Australia antigen in Hodgkin's disease

8 November 2022

23

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220503

Elevated antibody titers to Epstein-Barr virus in Hodgkin's disease

8 November 2022

24

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220503

Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis

8 November 2022

27

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220503

Infectious mononucleosis and the empirical risk of cancer

8 November 2022

28

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220503

Infectious mononucleosis and Hodgkin's disease

8 November 2022

29

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220503

IgM antibodies specific for Epstein-Barr virus in infectious mononucleosis without heterophil antibodies.

8 November 2022

30

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220503

Cellular Immunity and Herpesvirus Infections in Cardiac-Transplant Patients

8 November 2022

32

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220503

Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines

8 November 2022

33

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220503

Quantitative Evaluation of Epstein-Barr-Virus-Infected Mononuclear Peripheral Blood Leukocytes in Infectious Mononucleosis

8 November 2022

34

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220503

Antibodies to Epstein-Barr virus-associated nuclear antigen and to other viral and non-vical antigens in Hodgkin's Disease

8 November 2022

35

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220503

Hodgkin's disease in patients with previous infectious mononucleosis: 30 years' experience.

8 November 2022

36

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220503

Herpes zoster and impaired cell-associated immunity to the varicella-zoster virus in patients with Hodgkin's disease

8 November 2022

37

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220503

Oropharyngeal excretion of Epstein-Barr virus by renal transplant recipients and other patients treated with immunosuppressive drugs

8 November 2022

38

1 reference

https://api.crossref.org/works/10.1002/IJC.2910220503

8 November 2022

Identifiers

1 reference

release_gtp6svzt75efveusinwqztwzmu

12 September 2017

0 references

1 reference